Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Protecting Our Community: COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Protecting Our Community: COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04866303).
- Protective Behavioral Strategies and Brief Alcohol Interventions: Complete Statistical AnalysisIndependent statistical analysis of Protective Behavioral Strategies and Brief Alcohol Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01168726).
- Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: Complete Statistical AnalysisIndependent statistical analysis of Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Protego DF4 Post Approval Registry: Complete Statistical AnalysisIndependent statistical analysis of Protego DF4 Post Approval Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02243696).
- Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study: Complete Statistical AnalysisIndependent statistical analysis of Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00604383).
- PROTEKTIndependent statistical analysis of Kaletra in Combination With Antiretroviral Agents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01076179).
- PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria: Complete Statistical AnalysisIndependent statistical analysis of PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Protocol for Women at Increased Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Protocol for Women at Increased Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00291135).
- Protocol VIndependent statistical analysis of Treatment for CI-DME in Eyes With Very Good VA Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909791).
- Protocol1Independent statistical analysis of Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03560323).
- Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix: Complete Statistical AnalysisIndependent statistical analysis of Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI): Complete Statistical AnalysisIndependent statistical analysis of Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Proton Pump Inhibitors and Dysbiosis in Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Proton Pump Inhibitors and Dysbiosis in Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01458990).
- Proton Radiation for Chordomas and Chondrosarcomas: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation for Chordomas and Chondrosarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01449149).
- Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00592592).
- Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340495).
- Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01288235).
- Proton Therapy for Early Stage Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Proton Therapy for Early Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00614172).
- Proton-PANCIndependent statistical analysis of Study of Proton Therapy in Adjuvant Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03885284).
- Proton/Photon Rt – Benign Meningiomas(P92-13): Complete Statistical AnalysisIndependent statistical analysis of Proton/Photon Rt - Benign Meningiomas(P92-13): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02947984).
- PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region: Complete Statistical AnalysisIndependent statistical analysis of PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PROVE-AAAIndependent statistical analysis of Preferences for Open Vs. Endovascular Repair for Abdominal Aortic Aneurysm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03115346).
- PROVE-HCCIndependent statistical analysis of Trial Comparing PLA to HIGRT (PROVE-HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03402607).
- PROVENTIndependent statistical analysis of Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ProVentIndependent statistical analysis of Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ProVIDEIndependent statistical analysis of ProVee Urethral Expander System IDE Study (ProVIDE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05186740).
- Providing Accessible Diagnostic Evaluations and Psychoeducation for Autism Spectrum Disorder in Rural Southwest Virginia: Complete Statistical AnalysisIndependent statistical analysis of Providing Accessible Diagnostic Evaluations and Psychoeducation for Autism Spectrum Disorder in Rural Southwest Virginia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: Complete Statistical AnalysisIndependent statistical analysis of Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849822).
- Provision of HIV Self-Test Kit to Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Provision of HIV Self-Test Kit to Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03021005).
- ProvodineTM Decreases Hand Contamination: Complete Statistical AnalysisIndependent statistical analysis of ProvodineTM Decreases Hand Contamination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04023682).
- Proxalutamide Treatment for Hospitalized COVID-19 Patients: Complete Statistical AnalysisIndependent statistical analysis of Proxalutamide Treatment for Hospitalized COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04728802).
- PRP vs Corticosteroid in Baker’s Cyst: Complete Statistical AnalysisIndependent statistical analysis of PRP vs Corticosteroid in Baker's Cyst: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02249377).
- PRP vs PRP Plus IGF for Patellar Tendinosis: Complete Statistical AnalysisIndependent statistical analysis of PRP vs PRP Plus IGF for Patellar Tendinosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04350827).
- PRSAIndependent statistical analysis of Parent-Reported Symptom Assessments in Children Taking Multiple Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03849066).
- PRSTIndependent statistical analysis of Paediatric Rapid Sepsis Trigger (PRST) Tool: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04304235).
- PS PilotIndependent statistical analysis of The PortionSize Smartphone App Pilot (PS Pilot): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04494971).
- PS-010Independent statistical analysis of CryoCath Freezor CryoAblation Catheter System (CRYOFACTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621621).
- PS128 May Improve Off Duration on Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of PS128 May Improve Off Duration on Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04389762).
- PSADIndependent statistical analysis of Personal Sound Amplification Smartphone Application Feasibility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03652909).
- PSCIndependent statistical analysis of Vidofludimus Calcium for Primary Sclerosing Cholangitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03722576).
- Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions: Complete Statistical AnalysisIndependent statistical analysis of Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763124).
- Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02950467).
- Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01943994).
- Psilodep-RCTIndependent statistical analysis of Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03429075).
- PsiTODIndependent statistical analysis of Internet-delivered Psychotherapy for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02091856).
- PSMA PETIndependent statistical analysis of Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02611882).
- PSMA PreRPIndependent statistical analysis of Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919111).